Heightened immune response to flagellins in commensal gut microbes predicted future CD in healthy first-degree relatives of patients.

Thank you. Earlier today, Seer released financial results for the quarter and year ended December 31, 2025. If you've not received this news release or if you'd like to be added to the company's ...

Rising Pharmaceutical R&D Spending, Expanding Clinical Diagnostics Demand, and Rapid Advancement in Mass Spectrometry and Multi-Omics Technologies Accelerate Global Proteomics Market Growth.Austin, ...

Dynamic Image Analysis directly addresses micro-flow imaging’s inherent scalability and workflow limitations. Both ...

Refeyn, developer of pioneering mass photometry technology, expands its global adoption across contract research ...